Corporate alliances
By its very nature, translational research crosses the boundaries between academic research labs, corporate drug development and clinical application.
Historically, communication and cultural disconnections between academic and industry scientists have made this difficult. As a result, exciting discoveries and technologies have been lost in translation.
But when these collaborations are seamless—when a talented translator makes sure that we are all speaking the same language—great ideas take the fast track to becoming therapies that help patients. By collaborating with corporations, the Institute is able to move forward innovation at every stage of the pipeline—from earliest ideas to products ready for clinical trials—with the companies who have a track record of delivering results to patients around the world.
The Office of Corporate Alliances encourages these collaborations, and continues to grow participation in partnerships and attract support for promising research. With partner companies, the Institute has embarked on multiple new research projects across a wide spectrum of scientific disciplines. Through these projects, Institute scientists have the opportunity to engage in translational research with colleagues in industry, combining our intellectual, technical, and financial assets toward our common goal of conquering the diseases that cause blindness.
For more information, contact Mary Chatterton, Director of Corporate Alliances, at This e-mail address is being protected from spam bots, you need JavaScript enabled to view it or 617-912-2550.
